Journal article
Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: Case-control study nested within a population based screening programme in Australia
E Crowe, N Pandeya, JML Brotherton, AJ Dobson, S Kisely, SB Lambert, DC Whiteman
BMJ Online | BMJ PUBLISHING GROUP | Published : 2014
DOI: 10.1136/bmj.g1458
Open access
Abstract
Objective: To measure the effectiveness of the quadrivalent human papillomavirus (HPV) vaccine against cervical abnormalities four years after implementation of a nationally funded vaccination programme in Queensland, Australia. Design: Case-control analysis of linked administrative health datasets. Setting: Queensland, Australia. Participants: Women eligible for free vaccination (aged 12-26 years in 2007) and attending for their first cervical smear test between April 2007 and March 2011. High grade cases were women with histologically confirmed high grade cervical abnormalities (n=1062) and "other cases" were women with any other abnormality at cytology or histology (n=10 887). Controls we..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
No specific project funding was received but EC was supported by a salary from the University of Queensland and NHS Borders. DCW was supported by a Future Fellowship from the Australian Research Council (FT0990987). NP was supported by an early career fellowship from the National Health and Medical Research Council (631691). SK and AJD were supported by salaries from the University of Queensland. JMLB was supported by salary from the Victorian Cytology Service. SBL was supported by an early career fellowship from the National Health and Medical Research Council (GNT1036231) and is a Queensland Children's Medical Research Institute senior research fellow supported by the Children's Health Foundation Queensland (50025).